Extensive research shows that drinking alcohol increases the risk of cancer, and U.S. public-health authorities are following the example of other countries in increasing public awareness about th ...

NEW BEDFORD — A state agency will continue efforts to develop a more than $10 million offshore-wind-based, ocean-energy innovation center in New Bedford in 2025, despite national opposition to ...

Alcoholic beverages contribute to 9% of daily calorie intake for adults who drink and are linked to serious health issues, including liver disease and certain cancers. The Center for Science in ...

Moreover, Biogen’s valuation appears to be fairly priced at current levels, as indicated by a Discounted Cash Flow analysis projecting revenues through 2033. While the company has potential ...

Sugar-sweetened beverages also include energy drinks, fruit drinks and sports drinks that contain corn syrup, dextrose, fructose and other forms of sugar. Sugary drinks are leading sources of ...

But don’t expect the industry to condemn your glass of pinot. By Julie Creswell Business is booming for Per Se’s drinks. Its nonalcoholic hibiscus margarita can be found on restaurant menus in ...

While most of TRIP's drinks tend to focus on light, fruity flavours, you'll also find the TRIP Cold Brew: coffee infused with CBD providing all of the energy but none of the jitters. With 15mg of ...

Biogen Inc. (NASDAQ:BIIB), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025. The ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Biogen ( (BIIB ...

Biogen Inc. (NASDAQ:BIIB), a leader in biotechnology, announced the appointment of Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller, effective March 1, 2025 ...

U.S. biotech company Biogen, which commercialized a new treatment for Alzheimer's disease in collaboration with Japanese pharmaceutical company Eisai, is aiming to launch a subcutaneous injection ...